Trial
NCT00006451
Bone Marrow Transplantation in Treating Patients With Leukemia
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Graft Versus Host Disease
Intervention
anti-thymocyte globulin
Why stopped
Terminated (due to no accrual)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-03